Delivery Order SPE2DB20D1100-SPE2DB23FC5H1

Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $232
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-three thousand eight hundred eighty-nine dollars to Amerisourcebergen Drug Corporation for five hundred tablets of the prescription medication bupropion hydrochloride extended release three hundred milligrams. Amerisourcebergen Drug Corporation will fulfill the order as a division of its parent company, Amerisourcebergen Corporation, with place of performance in Conshohocken, Pennsylvania between September...
The Defense Logistics Agency awarded a delivery order valued at one hundred twenty-two thousand eight hundred eighty-eight dollars to Amerisourcebergen Drug Corporation for the supply of five hundred tablets of 150 milligram Bupropion hydrochloride extended-release tablets. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The firm fixed-price delivery order was awarded on September 8, 2023 and production...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred eighty-one thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of four hundred fifty-six thousand one hundred fifty-nine thousand seven hundred eighty-five bupropion hydrochloride extended-release three hundred milligram tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-eight thousand six hundred ten dollars to Amerisourcebergen Drug Corporation for the supply of four hundred fifty-six thousand one hundred ninety-eight tablets of 150mg bupropion hydrochloride extended release. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on August 30, 2023. As a major provider of pharmaceuticals and medical supplies to...
The Defense Logistics Agency awarded a $153,330 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 boxes containing 300 milligram tablets of bupropion hydrochloride extended release. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to support the Department of Defense's pharmaceutical needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 27-28, 2023. The fixed...
The Defense Logistics Agency awarded a $1,011.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 450 mg bupropion hydrochloride extended-release tablets. The prime contractor, Amerisourcebergen Drug Corporation, will deliver 30 tablets from its Conshohocken, Pennsylvania facility by August 17, 2023 to support the Defense Logistics Agency's pharmaceutical supply needs. No major subcontractors or set aside designations were indicated. The delivery order...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $275 to Amerisourcebergen Drug Corporation for the supply of 90 150mg tablets of bupropion hydrochloride extended release. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one day period of performance from July 5-6, 2023. No subcontractors or set aside designations were indicated. The order is consistent with DLA's mission to...
The Defense Logistics Agency awarded a $197.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 100mg bupropion hydrochloride sustained release. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 21, 2023. No subcontractors or set aside...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred ninety-four dollars and sixty-one cents to Amerisourcebergen Drug Corporation for five hundred tablets of 150mg bupropion hydrochloride sustained release. As a prime contractor for the Defense Logistics Agency, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania within the period of performance between July 12 and July...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at ninety thousand fifty-one dollars to Amerisourcebergen Drug Corporation for the supply of four hundred fifty-six thousand two hundred thirty tablets of bupropion hydrochloride extended release three hundred milligrams. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a period of performance spanning August thirtieth...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FC5H1
    Delivery Order

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at two hundred thirty-two dollars and thirty-nine cents to Amerisourcebergen Drug Corporation for the supply of ninety 150-milligram tablets of bupropion hydrochloride extended-release. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from July 12 through July 13, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set-aside designations were identified. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract to support the medical readiness of DOD personnel.

Generated 12/24/23, 6:05 PM